// App-Quantinova.ai

: Late Breaking Abstract - Effect of timapiprant, a DP2 antagonist, on airway inflammation in severe eosinophilic asthma

Researchers

Presenter

  • Rahul Shrimanker

Principal Investigators

  • Katie Borg

  • Clare Connolly

  • Samantha Thulborn

  • Jennifer Cane

  • Luzheng Xue

  • Gareth Hynes

  • Timothy Hinks

  • Maxim Kots

  • Luca Girardello

  • Stefano Petruzzelli

  • Jan Steiner

  • Shan Vinall

  • Mick Hunter

  • Roy Pettipher

  • Ian D Pavord

Medical Centers

  • Oxford Respiratory NIHR BRC and Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

  • Chiesi Farmaceutici, Global Clinical Development, Parma, Italy

  • CROS NT S.r.l, Verona, Italy

  • Oxford Therapeutics Consulting Ltd, Oxford, United Kingdom

  • PsiOxus Therapeutics Ltd., Abingdon, United Kingdom

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved